ANI Pharmaceuticals ANIP Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	94,23M	106,79M	116,55M	132,39M	131,65M	137,43M	138,04M	148,33M
Reddito operativo	1,71M	9,9M	12,4M	15,95M	8,71M	15,06M	5,53M	-11,4M
Reddito ante imposte	-5,73M	2,17M	5,25M	11,51M	947k	25,34M	-2,29M	-31,5M
Reddito netto	-4,65M	1,03M	5,84M	9,53M	749k	17,8M	-2,69M	-24,57M
Dividendi preferiti	-407k	-406k	-407k	-406k	-406k	-406k	-407k	-406k
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,67M	9,86M	12,35M	15,91M	8,68M	20,37M	5,44M	-13,93M
EBITDA	16,3M	24,6M	27,09M	31,16M	23,91M	29,74M	20,23M	4,35M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	128,62M	176,84M	201,58M	206,55M	208,48M	216,14M	316,39M	486,82M
Reddito operativo	20,08M	28,33M	35,36M	16,35M	-16,02M	-39,79M	-35,28M	48,4M
Reddito ante imposte	8,68M	16,35M	20,05M	3,16M	-25,96M	-56,06M	-62,67M	19,87M
Reddito netto	3,93M	-1,08M	15,49M	6,09M	-22,55M	-42,79M	-49,52M	17,15M
Dividendi preferiti	0	0	0	0	0	-190k	-1,63M	-1,63M
Utile base per azione (EPS)	0.339	-0.092	1.306	0.504	-1.812	-2.541	-2.829	0.839
UTILE OPERATIVO	20,01M	28,38M	34,81M	16,12M	-16,51M	-44,14M	-34,61M	48,24M
EBITDA	49,11M	57,16M	69,1M	61,04M	29,07M	9,83M	21,8M	108,19M